跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Acantha - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Acantha
Approved
STANDARD
Acantha
Hebei Tiancheng Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
22106506b088879c
Company
Hebei Tiancheng Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
22106506b088879c
Drug Approval Philippines Name
Acantha
Product Name
Acantha
Registration Number
DRP-10623-03
Brand Name
Acantha
Generic Name
Sitagliptin (as phosphate)
Dosage Form
Tablet
Dosage Strength
100 mg
Manufacturer
Hebei Tiancheng Pharmaceutical Co., Ltd.
Importer
AMB HK Enterprises Inc.
Distributor
Corbridge Group Phils., Inc.
Issuance Date
29 March 2022
Expiry Date
28 October 2026
Pharmacologic Category
Dipeptidyl peptidase 4 (DPP-4) Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
22106506b088879c
Type
Standard
Back to Philippines FDA Approvals